Portal de Periódicos da CAPES

MEDICAL TREATMENT OF SPASTICITY

1962; Wiley; Volume: 38; Linguagem: Inglês

10.1111/j.1600-0404.1962.tb01128.x

1600-0404

Ejner Pedersen,

Ophthalmology and Eye Disorders

Acta Neurologica ScandinavicaVolume 38, Issue s3 p. 85-93 MEDICAL TREATMENT OF SPASTICITY Ejner Pedersen, Ejner PedersenSearch for more papers by this author Ejner Pedersen, Ejner PedersenSearch for more papers by this author First published: October 1962 https://doi.org/10.1111/j.1600-0404.1962.tb01128.xCitations: 5 From the Department of Neurology (Heads: C. J. Munch-Petersen and Ejner Pedersen), Aarhus Kommunehospital, Aarhus, and the Multiple Sclerosis Hospital (Head: Ejner Pedersen), Ry, Denmark. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References Abdulian, D. H., W. R. Martin & K. R. Unna (1959): Drug effects on interneurones effects of central nervous system depressants on spinal cord reflexes. In The effects of pharmacologic agents on the nervous system. Edited by Francis J. Braceland, Baltimore, p. 72. Amols, W. (1956): Clinical experience with a new muscle relaxant, zoxazolamine. J.A. M.A. 160, 742. Arduini, A., & M. G. Arduini (1954): Effects of drugs and metabolic alterations on brain stem arousal mechanism. J. Pharmacol. & Exper. Therap. 110, 76. Basmajian, J. V., & A. Szatmari (1955): Chlorpromazine and human spasticity; an electromyographic study. Neurology 5, 856. Bein, H. J. (1958) see Pedersen, E., & P. Schleisner (1959): Effect of "Ciba 13.155" in the treatment of spastic paraplegia. Acta psych, et neurol. Scandinav. 34, 342. Bennett, A. E. (1941): Clinical investigations with curare in organic neurologic disorders. Am. J. M. Sc. 202, 102. Berger, F. M. (1947): Mode of action of myanesin. Brit. J. Pharmacol. 2, 241. Berger, F. M., & W. Bradley (1946): The pharmacological properties of α:β-dihydroxy-y-(2- methylphenoxy)-propane (myanesin). Brit. J. Pharmacol. 1, 265. Berger, F. M., & R. P. Schwartz (1948): Oral "myanesin" in treatment of spastic and hyperkinetic disorders. J.A.M.A. 137, 772. Blomberg, L.-H., & S. Kollberg (1961): Effekten av Lisidonil (CIBA) hos patienter med spastiska blåsrubbningar. Svenska Läkartidningen 58, 2992. Boozko, M., & M. Mumenthaler (1958): Modified pendulousness test to assess tonus of thigh muscles in spasticity. Neurology 8, 846. Boshes, B., H. Wachs, J. Brumlik, M. Mier & M. Petrovick (1960): Studies of tone, tremor, and speech in normal persons and parkinsonian patients. Neurology 10, 805. Bovet, D., F. Bovet-Nitti & G. B. Marini-Bettolo (1959): Curare and curare-like agents, Elsevier, Amsterdam. Burman, M. S. (1939): Therapeutic use of curare and erythroidine hydrochloride for spastic and dystonic states. Arch. Neurol. & Psychiat. 41, 307. Clarke, C. E., & R. D. Hotston (1948): Curare in oil in the treatment of spastic conditions. Brit. M. J. ii, 289. Craig, L. E. (1948): Curariform activity and chemical structure. Chem. Rev. 42, 285. Domino, E. F. (1956): The correlation between animal testing procedures and clinical effectiveness of centrally acting muscle relaxants of the mephenesin type. Ann. New York Acad. Sc. 64, 705. Dyrrsen, C., K. Hellgren & G. von Reis (1960): Treatment of muscular hypertonic states with prothipendyl (azacon). Opuscula Medica 7, 235. Eisenberg, S. H., & J. S. Neviaser (1957): The use of meprobamate in the treatment of skeletal muscle spasm. Ann. New York Acad. Sc. 67, 853. Finkelman, I., & N. B. Dobin (1949): Effect of α: β-dihydroxy-y-(2-methylphenoxy)-propane (lissiphen) on excitation of motor cortex and conduction through the pyramids. J. Nerv. & Ment. Dis. 109, 323. Foldes, F. F. (1957): Muscle relaxants in anesthesiology. Ch. C Thomas, Illinois. Folkers, K., & R. T. Major (1937): Isolation of erythroidine and alkaloid of curare action. J. Am. Chem. Soc. 59, 1580. Funderburk, W. H., & R. T. Woodcock (1955): Effects of 2-amino-5-chlorobenzoxazole on the central nervous system. Federation Proc. 14, 341. Gesler, R. M., & A. R. Surrey (1958): The central depressant profile of some substituted meta-thiazanones. J. Pharmacol. & Exper. Therap. 122, 517. Gibson, J. W., S. S. Bluestone & E. W. Lowman (1957): Zoxazolamine and/or chlorpromazine for muscle spasms. J.A.M.A. 165, 18. Gillette, H. E. (1957): The effect of meprobamate on cerebral palsy. Ann. New York Acad. Sc. 67, 859. Gruenberg, F. (1960): Chlormezanone (trancopal) in musculoskeletal disorders. Curr. Therap. Res. 2, 1. Harvey, A. M., & R. L. Masland (1941): Actions of curarizing preparations in the human. J. Pharmacol. & Exper. Therap. 73, 304. Hennemann, E., A. Kaplan & K. R. Unna (1949): A neuropharmacological study on the effect of myanesin (tolserol) on motor systems. J. Pharmacol. & Exper. Therap. 97, 331. Houde, R. W., & A. Wikler (1951): Delineation of the skin twitch response in dogs and the effects thereon of morphine, thiopental and mephenesin. J. Pharmacol. & Exper. Therap. 103, 236. Juul-Jensen, P., & E. Pedersen (1959): The effect of a polysynaptic inhibitor in the treatment of uninhibited neurogenic bladder. Dan. Med. Bull. 6, 256. Juul-Jensen, P., & E. Pedersen (October 1962): Unpublished data. Kamijo, K., & G. B. Koelle (1955): 2-amino-5-chlorobenzoxazole (McN-485, flexin), a long acting spinal cord depressant. Proc. Soc. Exper. Biol. & Med. 88, 565. Kearney, R. D. (1960): Use of trancopal as a muscle relaxant and tranquilizer in industrial medicine: Clinical experience in 220 patients. Curr. Therap. Res. 2, 127. King, E. E. (1954): Differential action of anesthetic and multineuronal blocking agents upon EEG arousal and recruitment responses evoked from the brain stem. Federation Proc. 13, 375. King, H. (1935): Curare alkaloids I. Tubocurarine. J. Chem. Soc. 57, 1381. Kollberg, S., I. Petersén & U. Selldén (October 1962): Electromyographic studies on the effect of lisidonil upon the striated muscle of the urethral sphincter. Brit. J. Urol. 34, 70. Kuhn, R. A., & D. S. Bickers (1948): An evaluation of curare in spasticity due to spinal-cord injuries. New England J. Med. 238, 615. Kurtzke, J. F., & J. Gylfe (October 1962): A new muscle relaxant in spasticity. Neurology 12, 343. Kaada, B. R. (1950): Site of action of myanesin (mephenesin, tolserol) in the central nervous system. J. Neurophysiol. 13, 89. Lund, M., & M. Langkilde (1960): Spasticité et spasmes de la sclérose en plagues, traités avec le librium. Arch, suisses de neurol., neurochir. & de psychiat. 87, 241. Marsh, D. F. (1955): Comparative pharmacological activity of 2-amino-5-chlorobenzoxazole (McN-485) and other mephenesin-like agents. Federation Proc. 14, 366. Mayle, F. C., P. D. Sullivan & T. L. Auth (1959): Chlorzoxazone (paraflex) in the treatment of spasticity. Med. Ann. Dist. Columbia 28, 499. Med. Letter on Drugs & Therap. 4, No. 2, October 1962. Millefiorine, M., & G. Donini (1958): Osservazioni sperimentali su un nuovo farmako miorilassante. Riv. speriment. freniat. 82, 472. Millichap, J. G., & R. Hadra (1956): Quantitative assessment of motor function in cerebral palsy. Neurology 6, 843. Naumann, B. (1960): Användning av ett nytt muskelrelaxans (chlormezanon) vid spasticitet. Svenska Läkartidningen 48, 3378. Pedersen, E., & P. Schleisner (1959): Effect of "Ciba 13.155" in the treatment of spastic paraplegia. Acta psychiat. & neurol. Scandinav. 34, 342. Pinelli, P. (1959): Terapia antispastica: azione inibente sul rilfesso H di un derivato della diaziono-triazina (2-idraziono-4,6 bisdietilamino-1,3,5-triazina dicloruro). Riv. neurol. 29, 151. Pinelli, P., & M. Valle (1960): Studio fisiopatologico dei riflessi muscolari nelle paresi spastiche (sui tests per la misura della spasticità). Arch. Sc. Med. 109, 1. Pugh, J. I., & G. E. H. Enderby (1947): Hemoglobinuria after intravenous myanesin. Lancet ii, 387. de Reuck, A. V. S. (October 1962): Curare and curare-like agents, Churchill, London. Riley, R. F., & F. M. Berger (1949): Preparation and pharmacological properties of the acid succinate of myanesin. Federation Proc. 8, 328. Rodriguez-Gomez, M., A. Valdes-Rodriguez & A. L. Drew (1956): Effects of zoxazolamine (flexin) in treatment of spasticity. J.A.M.A. 160, 752. Schaltenbrand, G. (1937): Myographische Untersuchungen in der Klinik. Deutsche Ztschr. f. Nervenheilk. 142, 1. Schlesinger, E. B. (1947): Therapeutic applications of curare and their physiologic implications. New York J. Med. 47, 1689. Schlesinger, E. B. (1957): The value of muscle relaxants in disorders of muscle tone. Ann. New York Acad. Sc. 67, 833. Spiegel, E. A., H. T. Wycis, H. W. Baird III, D. Rovner & C. Thur (1956): Pallidum and muscle tone. Neurology 6, 350. Stephen, C. R., & J. Chandy (1947): Clinical and experimental studies with myanesin (a preliminary report). Canad. M.A.J. 57, 463. Struppler, A. (1960): Neuere Ausblicke in der konservativen Therapie der Spastik. Der Nervenartz 31, 369. Surrey, A. R., W. G. Webb & R. M. Gesler (1958): Central nervous system depressants; the preparation of some 2-aryl-4-metathiazanones. J. Am. Chem. Soc. 80, 3469. Wartenberg, R. (1953): Diagnostic tests in neurology, The Year Book Publishers, Chicago. Watkins, M., & M. Hale (1957): Clinical evaluation of zoxazolamine (flexin) in children with cerebral palsy. J.A.M.A. 165, 830. West, R. (1932): Curare in man. Proc. Soc. Med. 25, 1107. Wiesendanger, M., & M. Mumenthaler (1959): Der Pendeltest. Ein Beitrag zur Objektivierung von muskulären Hypertonien. Schweiz. med. Wchnschr. 89, 1301. Wikler, A. (1945): Effects of morphine, nembutal, ether, and eserine on two-neuron and multineuron reflexes in the cat. Proc. Soc. Exper. Biol. & Med. 58, 193. Citing Literature Volume38, Issues3October 1962Pages 85-93 ReferencesRelatedInformation